Employee

Renee joined the National Bleeding Disorders Foundation Venture Fund, Pathway to Cures, in December 2022, spearheading fundraising and communication initiatives to support equity investments in companies developing cures, technologies, and therapies for inheritable blood and bleeding disorders. With 30 years of experience in non-profit work, Renee has excelled in professional fundraising for esteemed institutions such as Providence Health System, Ascension St.

Philip M. Gattone, M.Ed., is the president and chief executive officer of the National Bleeding Disorders Foundation (NBDF).

Peter Harvey serves as the Chief Business Officer for NBDF including oversight for finance & accounting, business development, conference & travel services, payer relations, and IT. Peter is a senior healthcare finance and operations executive with diverse experience in healthcare nonprofit finance & accounting, pharma/biotech HEOR and medical affairs business operations, academic medical/pediatric department and Hemophilia Treatment Center administration, plus PM&R medical practice and research foundation executive leadership.

Dawn has been a leader in the bleeding disorders community for many years.  As a parent of a son with hemophilia, she founded the Rocky Mountain Hemophilia & Bleeding Disorders Association in Bozeman, Montana, served as its Executive Director, and began their Family Camp. After moving to Pittsburgh, Pennsylvania, Dawn worked for the American Diabetes Association (ADA) as an Area Manager. Concurrently, she served as a board member for the Hemophilia Center of Western Pennsylvania for six years.

Kyra Calbero graduated from Pacific University in June of 2019 with a degree in Public Health and a minor in Disability Studies. After graduation, she worked in Forest Grove, OR as a Skills Trainer at a school serving teens with severe behavioral disabilities. As of July 2020, she moved back home to Hawai`i to work for the National Hemophilia Foundation as the Hawai`i Chapter's Program Manager.

Dr. Michael Recht entered the role of Chief Medical and Scientific Officer at the foundation in early 2023.

Prior to this role, he served as the Chief Science Officer (CSO) of the American Thrombosis and Hemostasis Network (ATHN).  As ATHN's CSO, Dr. Recht worked at the strategic and policy level to inform the scientific direction of the organization.